/
PHGE
$0.36-$0.04 (-9.25%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$4.7M
12M shares
52-week range
$0.30 – $14.71
0% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
XASE
CS
Borrow rate
332.86%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-1025.64
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $210.0K | $0 | $0 | $0 | $0 | $871.0K | $1.8M | $2.9M |
| Gross profit | −$210.0K | $0 | $0 | $0 | $0 | −$871.0K | −$1.8M | −$2.9M |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $9.6M | $14.0M | $21.6M | $22.7M | $16.2M | $19.0M | $24.7M | $23.3M |
| Operating income | −$13.1M | −$22.2M | −$30.3M | −$35.5M | −$27.2M | −$27.7M | −$39.0M | −$32.9M |
| EBITDA | −$12.5M | −$21.9M | −$29.6M | −$32.9M | −$23.7M | −$22.8M | −$13.1M | −$32.3M |
| Net income | −$12.7M | −$20.6M | −$30.1M | −$36.2M | −$28.3M | −$26.2M | −$17.7M | −$36.2M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -122.74 | -15.96 | -24.70 | -264.67 | -180.31 | -96.90 | -27.93 | -22.19 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $24M | $-5.85 | $-5.85–$-5.85 | 1 |
| 2027 | $57M | $-6.01 | $-6.01–$-6.01 | 1 |
| 2028 | $14M | $-4.57 | $-4.57–$-4.57 | 1 |
| 2029 | $20M | $-31.54 | $-31.54–$-31.54 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.00
Price
$0.36
Implied downside
-100%
Peer comparison
BiomX Inc.
BiomX Inc is a company focused on acquiring and further developing technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response sectors. The Company's portfolio is built around the growing need for earlier and more accurate threat detection, particularly as UAVs and other autonomous systems play a larger role in defense and homeland security.
www.biomx.com- Employees
- 20
- IPO / List date
- Mar 13, 2019
- HQ
- DOVER, DE
Held by traders on TradeandTell
No one on the platform currently holds PHGE.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PHGE as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-11-25 | 1-for-19reverse |
| 2024-08-26 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded PHGE yet.
